RVMD Form 144: Proposed sale of 3,000 shares

Morgan Stanley Smith Barney LLC submitted a Form 144 notice listing a proposed sale of 3,000 common shares of the issuer.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice listing a proposed sale of 3,000 common shares of the issuer. The filing also reports that Mark A. Goldsmith sold 15,394 common shares on 12/16/2025 for $1,182,525.52.

Insights

Securities Compliance Officer

Form 144 lists a broker-led proposed sale and a recent insider sale.

The notice shows a proposed sale of 3,000 common shares by Morgan Stanley Smith Barney LLC, which is presented as the security to be sold. The filing separately records an actual sale by Mark A. Goldsmith of 15,394 shares on 12/16/2025 for $1,182,525.52.

These entries are routine SEC sale notices; cash-flow treatment and any resale conditions are not disclosed in the excerpt. Subsequent regulatory filings or broker statements would provide execution details if the proposed sale occurs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does RVMD's Form 144 report?

The Form 144 reports a proposed sale of 3,000 common shares by Morgan Stanley Smith Barney LLC and records an actual sale by Mark A. Goldsmith of 15,394 shares on 12/16/2025 for $1,182,525.52.

Who is listed as selling RVMD shares in this filing?

Morgan Stanley Smith Barney LLC is listed for a proposed sale of 3,000 common shares. The filing also shows Mark A. Goldsmith sold 15,394 shares on 12/16/2025 for $1,182,525.52.

When did the recorded insider sale of RVMD occur?

The recorded sale by Mark A. Goldsmith occurred on 12/16/2025. That transaction is shown as 15,394 common shares with proceeds of $1,182,525.52 in the provided excerpt.

Does the Form 144 state how the proceeds will be used?

The excerpt does not specify any use of proceeds or who receives sale proceeds for the proposed 3,000 shares. The filing lists quantities and a completed sale by Mark A. Goldsmith but does not describe proceeds allocation for the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001246842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	JONATHAN GOLDSMITH REVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	306060.00	198173397	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2014	Founders Shares	ISSUER			3000	11/25/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK A GOLDSMITH 700 Saginaw Drive Redwood City CA 94063	Common	12/16/2025	15394	1182525.52

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark A Goldsmith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)